Actos pioglitazone peroxisome proliferator-activated receptor-gamma regulatory update

The U.K.'s National Institute for Clinical Excellence (NICE) advised

Read the full 91 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE